Fortress Biotech Ownership 2024 | Who Owns Fortress Biotech Now?


OverviewRevenueFinancialsChart

Institutional Ownership

0.96%

Insider Ownership

21.21%

Retail Ownership

77.83%

Institutional Holders

1.00

Fortress Biotech Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
B. RILEY WEALTH ADVISORS, INC.0.96%0.00%144,700144,700100.00%42,006Mar 31, 2024

Fortress Biotech's largest institutional shareholder is B. RILEY WEALTH ADVISORS, INC., holding 0.96% of the company's total share outstanding, currently valued at $42.01K. The top 10 institutional shareholders own together 0.96% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
B. RILEY WEALTH ADVISORS, INC.0.96%0.00%144,700144,700100.00%42,006Mar 31, 2024

The largest Fortress Biotech shareholder by % of total assets is B. RILEY WEALTH ADVISORS, INC.. The company owns 144.70K shares of Fortress Biotech (FBIO), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
B. RILEY WEALTH ADVISORS, INC.0.96%0.00%144,700144,700100.00%42,006Mar 31, 2024

As of Mar 31 2024, Fortress Biotech's largest institutional buyer is B. RILEY WEALTH ADVISORS, INC.. The company purchased 144.70K stocks of FBIO, valued at $42.01K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
B. RILEY WEALTH ADVISORS, INC.0.96%0.00%144,700144,700100.00%42,006Mar 31, 2024

As of Mar 31 2024, Fortress Biotech's biggest institutional seller is B. RILEY WEALTH ADVISORS, INC.. The company sold 144.70K shares of FBIO, valued at $42.01K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Fortress Biotech Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.25%130,700--Mar 31, 2024
VANGUARD EXPLORER FUND0.14%1,732,308--Jan 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.09%100,000--Mar 28, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%10,826--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.02%112,543--Mar 31, 2024
SSGA FUNDS0.01%3,657--Feb 29, 2024
World Funds Trust0.01%4,633--Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,841--Mar 31, 2024
Fidelity Commonwealth Trust II0.01%54,189--Aug 31, 2023
VANGUARD INDEX FUNDS0.01%3,286,551--Mar 31, 2024
ALPS ETF Trust0.01%96,454--Feb 29, 2024
DELAWARE GROUP EQUITY FUNDS IV0.01%6,666--Mar 28, 2024
World Funds Trust0.01%69,500--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%809,169--Feb 29, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%151,271--Mar 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%11,060--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%29,605--Mar 31, 2024
Calvert Variable Products, Inc.0.00%5,129--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%57,880--Mar 31, 2024
SunAmerica Specialty Series0.00%518--Apr 30, 2021
GPS Funds I0.00%4,893--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%4,058--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%26,240--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%2,167--Mar 31, 2024
Virtus Strategy Trust0.00%16,242--Mar 28, 2024
SCHWAB CAPITAL TRUST0.00%29,965--Feb 29, 2024
ADVISORS' INNER CIRCLE FUND0.00%16,935--Jan 31, 2024
AdvisorShares Trust0.00%2,136--Mar 28, 2024
Meeder Funds0.00%2,533--Mar 31, 2024
RBB FUND, INC.0.00%44,900--Feb 29, 2024
Global X Funds0.00%20,888--Jan 31, 2024
ALLSPRING MASTER TRUST0.00%25,560--Feb 29, 2024
NORTHERN FUNDS0.00%40,085--Mar 28, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%14,000--Mar 31, 2024
RYDEX SERIES FUNDS0.00%702--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%551,143--Mar 31, 2024
ProFunds0.00%1,564--Mar 31, 2024
RUSSELL INVESTMENT FUNDS0.00%14,968--Mar 31, 2024
PGIM ETF TRUST0.00%8,345--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%2,739--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%242,299--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%401--Dec 31, 2023
VALIC Co I0.00%27,197--Feb 29, 2024
LAZARD FUNDS INC0.00%3,447--Mar 31, 2024
PENN SERIES FUNDS INC0.00%2,400--Mar 28, 2024
Guggenheim Active Allocation Fund0.00%432--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%9,554--Mar 31, 2024
FLEXSHARES TRUST0.00%5,076--Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%8,195--Jan 31, 2024
RYDEX VARIABLE TRUST0.00%71--Dec 31, 2023
TIAA-CREF FUNDS0.00%154,747--Mar 31, 2024
Goldman Sachs ETF Trust0.00%4,627--Feb 29, 2024
USAA MUTUAL FUNDS TRUST0.00%10,149--Jan 31, 2024
PACE SELECT ADVISORS TRUST0.00%13,612--Jan 31, 2024
PROSHARES TRUST0.00%10,574--Feb 29, 2024
Brighthouse Funds Trust II0.00%30,568--Mar 31, 2024
Advisors' Inner Circle Fund II0.00%28,573--Jan 31, 2024
VANGUARD WELLINGTON FUND0.00%13,107--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%3,102--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%61,000--Mar 31, 2024
ETF Series Solutions0.00%501--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%8,091--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%100--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%12,816--Mar 31, 2024
EQ ADVISORS TRUST0.00%13,500--Mar 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%27,855--Dec 31, 2023
PACIFIC SELECT FUND0.00%24,282--Mar 31, 2024
iSHARES TRUST0.00%100,939--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%6,011--Dec 31, 2023
Goldman Sachs Trust II0.00%33,600--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%663--Jan 31, 2024
PRINCIPAL FUNDS, INC.0.00%11,861--Feb 29, 2024
Bridge Builder Trust0.00%8,304--Mar 31, 2024
BLACKROCK FUNDS0.00%11,540--Mar 28, 2024
BlackRock Variable Series Funds, Inc.0.00%7,258--Mar 31, 2024
Advisors' Inner Circle Fund III0.00%103--Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%1,857--Mar 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%13,200--Feb 29, 2024
John Hancock Funds II0.00%9,268--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%260260-Mar 31, 2024

Fortress Biotech's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 130.70K shares, compromising 0.25% of its total assets.

Fortress Biotech Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 241-
30 Sep, 2347-2.08%
30 Jun, 2348-12.73%
31 Mar, 235514.58%
31 Dec, 2248-14.29%
30 Sep, 2256-9.68%
30 Jun, 2262-22.50%
31 Mar, 2280-5.88%
31 Dec, 2185-
30 Sep, 2185-3.41%
30 Jun, 21886.02%
31 Mar, 2183-4.60%
31 Dec, 208714.47%
30 Sep, 20764.11%
30 Jun, 207332.73%
31 Mar, 20551.85%
31 Dec, 195410.20%
30 Sep, 19494.26%
30 Jun, 1947-2.08%
31 Mar, 1948-14.29%
31 Dec, 1856-13.85%
30 Sep, 18653.17%
30 Jun, 1863-3.08%
31 Mar, 186510.17%
31 Dec, 17591.72%
30 Sep, 175811.54%
30 Jun, 17528.33%
31 Mar, 1748-9.43%
31 Dec, 1653-1.85%
30 Sep, 1654-5.26%
30 Jun, 165723.91%
31 Mar, 164615.00%
31 Dec, 15402.56%
30 Sep, 1539-11.36%
30 Jun, 15442100.00%
31 Mar, 152-

As of 31 Mar 24, 1 institutions are holding Fortress Biotech's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24144,700-
30 Sep, 2319,944,606-17.35%
30 Jun, 2324,130,367-15.64%
31 Mar, 2328,604,2074.06%
31 Dec, 2227,489,482-8.48%
30 Sep, 2230,036,713-2.52%
30 Jun, 2230,813,233-13.33%
31 Mar, 2235,552,24410.12%
31 Dec, 2132,286,0516.58%
30 Sep, 2130,293,6750.96%
30 Jun, 2130,005,735-4.05%
31 Mar, 2131,272,237-2.12%
31 Dec, 2031,949,4843.69%
30 Sep, 2030,812,66636.36%
30 Jun, 2022,595,826145.37%
31 Mar, 209,208,94233.61%
31 Dec, 196,892,5494.44%
30 Sep, 196,599,7866.81%
30 Jun, 196,179,053-5.86%
31 Mar, 196,563,829-8.30%
31 Dec, 187,158,140-15.18%
30 Sep, 188,438,85810.84%
30 Jun, 187,613,74112.83%
31 Mar, 186,747,97511.84%
31 Dec, 176,033,499-1.13%
30 Sep, 176,102,6980.76%
30 Jun, 176,056,921-6.42%
31 Mar, 176,472,554-3.43%
31 Dec, 166,702,677-6.20%
30 Sep, 167,145,680-12.01%
30 Jun, 168,120,56127.06%
31 Mar, 166,391,0760.88%
31 Dec, 156,335,106-44.63%
30 Sep, 1511,442,30634.97%
30 Jun, 158,477,50612410.89%
31 Mar, 1567,761-

Fortress Biotech (FBIO) has 144.70K shares outstanding as of 31 Mar 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.96%-
30 Sep, 2318.02%3.21%
30 Jun, 2323.68%3.00%
31 Mar, 2328.07%2.93%
31 Dec, 2230.93%2.74%
30 Sep, 2233.59%2.79%
30 Jun, 2234.72%2.04%
31 Mar, 2241.22%2.64%
31 Dec, 2139.52%2.85%
30 Sep, 2137.24%2.71%
30 Jun, 2137.06%2.48%
31 Mar, 2138.68%1.96%
31 Dec, 2044.37%2.71%
30 Sep, 2040.49%3.73%
30 Jun, 2032.96%15.67%
31 Mar, 2014.50%9.14%
31 Dec, 1912.60%9.35%
30 Sep, 1911.61%8.78%
30 Jun, 1911.50%6.28%
31 Mar, 1913.53%6.21%
31 Dec, 1814.76%4.16%
30 Sep, 1818.83%6.11%
30 Jun, 1817.55%6.97%
31 Mar, 1815.87%7.88%
31 Dec, 1714.19%6.32%
30 Sep, 1714.99%6.72%
30 Jun, 1714.94%5.81%
31 Mar, 1716.04%5.81%
31 Dec, 1616.61%5.24%
30 Sep, 1617.81%4.29%
30 Jun, 1620.37%7.84%
31 Mar, 1616.12%8.93%
31 Dec, 1513.44%1.59%
30 Sep, 1529.03%6.18%
30 Jun, 1521.67%70214.17%
31 Mar, 150.18%-

As of 31 Mar 24, Fortress Biotech is held by 0.96% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 241-
30 Sep, 231730.77%
30 Jun, 2313-50.00%
31 Mar, 232673.33%
31 Dec, 2215-28.57%
30 Sep, 2221-25.00%
30 Jun, 2228-9.68%
31 Mar, 2231-24.39%
31 Dec, 214117.14%
30 Sep, 2135-5.41%
30 Jun, 213712.12%
31 Mar, 2133-32.65%
31 Dec, 204913.95%
30 Sep, 2043-14.00%
30 Jun, 205066.67%
31 Mar, 203015.38%
31 Dec, 19268.33%
30 Sep, 192414.29%
30 Jun, 192116.67%
31 Mar, 1918-18.18%
31 Dec, 1822-29.03%
30 Sep, 1831-11.43%
30 Jun, 183520.69%
31 Mar, 182911.54%
31 Dec, 1726-18.75%
30 Sep, 173239.13%
30 Jun, 17234.55%
31 Mar, 1722-
31 Dec, 162210.00%
30 Sep, 1620-41.18%
30 Jun, 1634100.00%
31 Mar, 1617-
31 Dec, 151721.43%
30 Sep, 1514-65.85%
30 Jun, 15411950.00%
31 Mar, 152-

1 institutional shareholders have increased their position in FBIO stock as of 31 Mar 24 compared to 17 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24--
30 Sep, 2312-20.00%
30 Jun, 231566.67%
31 Mar, 239-35.71%
31 Dec, 2214-12.50%
30 Sep, 2216-27.27%
30 Jun, 2222-21.43%
31 Mar, 222816.67%
31 Dec, 2124-
30 Sep, 2124-17.24%
30 Jun, 21293.57%
31 Mar, 212827.27%
31 Dec, 202257.14%
30 Sep, 2014180.00%
30 Jun, 205-44.44%
31 Mar, 209-18.18%
31 Dec, 1911-15.38%
30 Sep, 19138.33%
30 Jun, 1912-20.00%
31 Mar, 1915-6.25%
31 Dec, 181633.33%
30 Sep, 1812-14.29%
30 Jun, 1814-17.65%
31 Mar, 181713.33%
31 Dec, 171525.00%
30 Sep, 1712-14.29%
30 Jun, 1714-
31 Mar, 171416.67%
31 Dec, 1612-20.00%
30 Sep, 161536.36%
30 Jun, 1611-8.33%
31 Mar, 1612-20.00%
31 Dec, 1515-
30 Sep, 15151400.00%
30 Jun, 151-
31 Mar, 15--

- institutional shareholders have reduced their position in FBIO stock as of 31 Mar 24 compared to 12 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 241-144,700-0.96%-1---
30 Sep, 2347-2.08%19,944,606-17.35%18.02%3.21%1730.77%12-20.00%
30 Jun, 2348-12.73%24,130,367-15.64%23.68%3.00%13-50.00%1566.67%
31 Mar, 235514.58%28,604,2074.06%28.07%2.93%2673.33%9-35.71%
31 Dec, 2248-14.29%27,489,482-8.48%30.93%2.74%15-28.57%14-12.50%
30 Sep, 2256-9.68%30,036,713-2.52%33.59%2.79%21-25.00%16-27.27%
30 Jun, 2262-22.50%30,813,233-13.33%34.72%2.04%28-9.68%22-21.43%
31 Mar, 2280-5.88%35,552,24410.12%41.22%2.64%31-24.39%2816.67%
31 Dec, 2185-32,286,0516.58%39.52%2.85%4117.14%24-
30 Sep, 2185-3.41%30,293,6750.96%37.24%2.71%35-5.41%24-17.24%
30 Jun, 21886.02%30,005,735-4.05%37.06%2.48%3712.12%293.57%
31 Mar, 2183-4.60%31,272,237-2.12%38.68%1.96%33-32.65%2827.27%
31 Dec, 208714.47%31,949,4843.69%44.37%2.71%4913.95%2257.14%
30 Sep, 20764.11%30,812,66636.36%40.49%3.73%43-14.00%14180.00%
30 Jun, 207332.73%22,595,826145.37%32.96%15.67%5066.67%5-44.44%
31 Mar, 20551.85%9,208,94233.61%14.50%9.14%3015.38%9-18.18%
31 Dec, 195410.20%6,892,5494.44%12.60%9.35%268.33%11-15.38%
30 Sep, 19494.26%6,599,7866.81%11.61%8.78%2414.29%138.33%
30 Jun, 1947-2.08%6,179,053-5.86%11.50%6.28%2116.67%12-20.00%
31 Mar, 1948-14.29%6,563,829-8.30%13.53%6.21%18-18.18%15-6.25%
31 Dec, 1856-13.85%7,158,140-15.18%14.76%4.16%22-29.03%1633.33%
30 Sep, 18653.17%8,438,85810.84%18.83%6.11%31-11.43%12-14.29%
30 Jun, 1863-3.08%7,613,74112.83%17.55%6.97%3520.69%14-17.65%
31 Mar, 186510.17%6,747,97511.84%15.87%7.88%2911.54%1713.33%
31 Dec, 17591.72%6,033,499-1.13%14.19%6.32%26-18.75%1525.00%
30 Sep, 175811.54%6,102,6980.76%14.99%6.72%3239.13%12-14.29%
30 Jun, 17528.33%6,056,921-6.42%14.94%5.81%234.55%14-
31 Mar, 1748-9.43%6,472,554-3.43%16.04%5.81%22-1416.67%
31 Dec, 1653-1.85%6,702,677-6.20%16.61%5.24%2210.00%12-20.00%
30 Sep, 1654-5.26%7,145,680-12.01%17.81%4.29%20-41.18%1536.36%
30 Jun, 165723.91%8,120,56127.06%20.37%7.84%34100.00%11-8.33%
31 Mar, 164615.00%6,391,0760.88%16.12%8.93%17-12-20.00%
31 Dec, 15402.56%6,335,106-44.63%13.44%1.59%1721.43%15-
30 Sep, 1539-11.36%11,442,30634.97%29.03%6.18%14-65.85%151400.00%
30 Jun, 15442100.00%8,477,50612410.89%21.67%70214.17%411950.00%1-
31 Mar, 152-67,761-0.18%-2---

Fortress Biotech Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 15, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.48$37.42K127,500
Jul 12, 2024Jin Davidofficer Chief Financial OfficerP-PurchaseBuy500$7.50$3.75K500
Jul 11, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.39$36.97K122,500
Jul 10, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.35$36.76K117,500
Jul 01, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy20,000$1.64$32.72K2,893,905
May 20, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$1.76$17.59K2,873,905
May 20, 2024Klein Dovdirector-S-SaleSell10,000$1.89$18.90K53,400
Jan 09, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy50,000$2.38$118.77K2,863,905
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M2,597,440

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 15, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.48$37.42K127,500
Jul 12, 2024Jin Davidofficer Chief Financial OfficerP-PurchaseBuy500$7.50$3.75K500
Jul 11, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.39$36.97K122,500
Jul 10, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.35$36.76K117,500
Jul 01, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy20,000$1.64$32.72K2,893,905
May 20, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$1.76$17.59K2,873,905
Jan 09, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy50,000$2.38$118.77K2,863,905
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M2,597,440

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 20, 2024Klein Dovdirector-S-SaleSell10,000$1.89$18.90K53,400

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 15, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.48$37.42K127,500
Jul 12, 2024Jin Davidofficer Chief Financial OfficerP-PurchaseBuy500$7.50$3.75K500
Jul 11, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.39$36.97K122,500
Jul 10, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy5,000$7.35$36.76K117,500
Jul 01, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy20,000$1.64$32.72K2,893,905
May 20, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy10,000$1.76$17.59K2,873,905
May 20, 2024Klein Dovdirector-S-SaleSell10,000$1.89$18.90K53,400
Apr 02, 2024Jin Davidofficer Chief Financial OfficerA-AwardBuy2,352$1.70$4.00K238,268
Jan 09, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy50,000$2.38$118.77K2,863,905
Jan 03, 2024Lu Lucydirector-A-AwardBuy3,333--11,890
Jan 03, 2024Lorenz Kevindirector-A-AwardBuy3,333--24,304
Jan 03, 2024LOBELL J JAYdirector-A-AwardBuy6,666--115,692
Jan 03, 2024Klein Dovdirector-A-AwardBuy6,666--63,400
Jan 03, 2024Hoenlein Malcolmdirector-A-AwardBuy3,333--39,042
Jan 03, 2024Harvey Jimmiedirector-A-AwardBuy6,666--69,999
Jan 03, 2024WEISS MICHAEL Sdirector, 10 percent owner, officer See RemarksA-AwardBuy216,465--1,346,985
Jan 03, 2024Rowinsky Eric Kdirector-A-AwardBuy6,666--68,797
Jan 03, 2024ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanA-AwardBuy216,465--2,813,905
Dec 22, 2023Jin Davidofficer Chief Financial OfficerA-AwardBuy140,000--235,916
Nov 16, 2023ROSENWALD LINDSAY A MDdirector, 10 percent owner, officer President, CEO & ChairmanP-PurchaseBuy1,567,515$1.70$2.66M2,597,440

The last insider sell of Fortress Biotech's stock was made by Klein Dov on May 20 2024, selling 10,000 shares at $1.89 per share (valued at $18.90K). The last insider buy of FBIO was made by ROSENWALD LINDSAY A MD on Jul 15 2024, buying 5,000 shares at $7.48 per share (worth $37.42K).

Fortress Biotech Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20243--
Q2 202431300.00%
Q1 202410--
Q4 20235--
Q3 20233--
Q2 20232--
Q1 202315--
Q4 202261600.00%
Q3 2022-1-
Q2 20221--
Q1 20228--
Q4 202141400.00%
Q3 202141400.00%
Q2 20211--
Q1 202185160.00%
Q4 20201--
Q3 202021200.00%
Q2 20201--
Q1 20208--
Q4 20191--

3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Fortress Biotech's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20243--
Q2 202421200.00%
Q1 20241--
Q4 20234--
Q3 20233--
Q2 2023---
Q1 20236--
Q4 20224--
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021-1-
Q3 2021-1-
Q2 2021---
Q1 20211520.00%
Q4 2020---
Q3 202021200.00%
Q2 2020---
Q1 20201--
Q4 20191--

As of Q3 2024, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Fortress Biotech's stocks.

Fortress Biotech Peer Ownership


TickerCompany
CKPTCheckpoint Therapeutics, Inc.
ACHLAchilles Therapeutics plc
RVPHReviva Pharmaceuticals Holdings, Inc.
RNAZTransCode Therapeutics, Inc.
APTOAptose Biosciences Inc.
ACADACADIA Pharmaceuticals Inc.
CABACabaletta Bio, Inc.
ATHAAthira Pharma, Inc.
KODKodiak Sciences Inc.
EYENEyenovia, Inc.
MBIOMustang Bio, Inc.
CGTXCognition Therapeutics, Inc.
PIRSPieris Pharmaceuticals, Inc.
ATXIAvenue Therapeutics, Inc.
ALRNAileron Therapeutics, Inc.
LUMOLumos Pharma, Inc.

FBIO Ownership FAQ


Fortress Biotech is owned by institutional shareholders (0.96%), insiders (21.21%), and public (77.83%). The largest institutional shareholder of Fortress Biotech is B. RILEY WEALTH ADVISORS, INC. (0.96% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.25% of total shares).

Fortress Biotech's major institutional shareholders are B. RILEY WEALTH ADVISORS, INC.. The top five shareholders own together 0.96% of the company's share outstanding.

As of Mar 2024, there are 1 institutional shareholders of Fortress Biotech.

B. RILEY WEALTH ADVISORS, INC owns 144.7K shares of Fortress Biotech, representing 0.96% of the company's total shares outstanding, valued at $42.01K (as of Mar 2024).